Throughout life, our cells are constantly exposed to environmental and internal factors that can damage DNA. While such DNA ...

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on patients' lives with the presentation of 46 abstracts at the upcoming 2025 Fall ...

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...